Epic, Mayo Clinic to tap IBM Watson's supercomputer

IBM Watson Health, Epic and Mayo Clinic are collaborating to advance patient health by applying the cognitive computing capabilities of Watson to EHRs.

Combining the reach and capabilities of the three organizations will help patients and providers benefit from more rapid and thorough analysis of the medical factors that could impact an individual's health and wellness, according to the announcement.

Epic has more than 350 customers who exchanged more than 80 million medical records in the last 12 months, both within and outside the Epic community. Interoperability with Watson will enable these institutions to apply the cognitive capabilities of Watson to these records through secure, cloud-based Watson services, providing greater clinical insight to help personalize healthcare.

Together, Watson and Epic software could be used to develop patient treatment protocols, personalize patient management for chronic conditions, and intelligently assist doctors and nurses by providing relevant evidence from the worldwide body of medical knowledge, putting new insight into the hands of clinical staff. Providers will be able to share patient-specific data with Watson in real time, within workflows, allowing Watson to bring forth critical evidence from medical literature and case studies that are most relevant to the patient's care.

Epic plans to embed Watson's cognitive computing capabilities into its advanced decision support offerings through the use of open standards, including Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) Application Programming Interfaces (APIs). Connecting through Epic's open API, the two systems will extend clinician expertise and help caregivers access knowledge more quickly. 

"Accessing Watson's virtual brainpower from the Epic platform is energizing from a creative standpoint," said Epic President Carl Dvorak. "We are bringing another level of cognitive computing and augmented intelligence to mainstream healthcare, to improve safety and outcomes for patients globally."

"This is just the first step in our vision to bring more personalized care to individual patients by connecting traditional sources of patient information with the growing pools of dynamic and constantly growing healthcare information," said Mike Rhodin, senior vice president, IBM Watson. 

IBM and Mayo Clinic are already working together to pioneer cognitive computing in clinical trials matching for cancer patients. Watson's speed and accuracy allows physicians to enroll patients more quickly in the clinical trials that best meet individual patient needs. Over one million patients are seen at Mayo Clinic each year and more than 1,000 clinical trials are available to match patients to at any given time.  

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.